CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
July 20, 2023—Siemens Healthineers announced that its Atellica CI analyzer for immunoassay and clinical chemistry testing has received FDA clearance and is now available in many countries.
The Atellica CI analyzer makes it possible for standalone and satellite labs to have the same reagents, consumables, and intelligent software as the company’s flagship Atellica Solution. The analyzer features random access sampling, microvolume aspiration, and automatic maintenance and quality control scheduling to enable labs to deliver more predictable sample turnaround times. Chemistry and immunoassay engines run independently so throughput is not compromised if one of the two needs to stop. More than 50 assays can deliver results in less than 14 minutes.